Minimize Uncertainty – Make Informed Decisions – Succeed

Endocrinology

Endocrinology Today—January 13, 2026

January 13, 2026BioPharma and Tech News,T1Dosteoporosis,type 2 diabetes,type 1 diabetes,Acromegaly,Teplizumab,Endocrinology News,Continuous Glucose Monitoring,MiniMed 780G,AI diabetes tools,bone mineral density

This weekly Endocrinology update highlights key developments spanning…

by LucidQuest

Lucid Diligence Brief - Tech

Lucid Diligence Brief: Mirador Therapeutics $250 million Series B in immuno-fibrotic disease space

January 13, 2026venture capital,clinical trials,precision medicine,immunology,biopharma,Lucid Diligence Brief,payer access,diligence,inflammatory bowel disease,fibrosisIPO

Lucid Diligence Brief: Mirador Therapeutics $250 million Series B in…

by Timos Papagatsias

Artificial_Intelligence

AI in Healthcare and Digital Health Video Recap —January 12, 2026

January 12, 2026Oura Ring,drug safety,Insilico Medicine,BioPharma and Tech News,GLP-1,OpenAI,AI in Healthcare and Digital Health,Rentosertib,ChatGPT Health,OpenAI for Healthcare,Consumer Electronics Show 2026,Wearable health technology,Predictive toxicologyArtificial intelligence in medicine,HealthBench

Here’s your AI in Healthcare and Digital Health video brief covering recent…

by Timos Papagatsias

Onco_background

Oncology Today—January 12, 2026

January 12, 2026prostate cancer,BioPharma and Tech News,Pancreatic cancer,antibody drug conjugate,Orphan Drug Designation,Oncology News,metastatic colorectal cancer,Intraoperative imaging,EncorafenibCetuximab,NTRK fusion-positive tumors

This week’s Oncology update highlights major oncology regulatory milestones,…

by LucidQuest

Hematology

Hematology Video Recap—January 12, 2026

January 12, 2026Lunsumio,Tafasitamab,mosunetuzumab,Lenalidomide,roche,Rituximab,Duvelisib,takeda,cutaneous T-cell lymphoma,Copiktra,Multiple Myeloma,Hematology News,Roxadustat,Tecvayli,BeOne Medicines,Rusfertide,BioPharma and Tech News,Myelodysplastic syndromes,Mycosis fungoides,Daratumumab,syndax pharmaceuticals,Sézary syndrome,Darzalex,chronic lymphocytic leukemia,follicular lymphoma,Sonrotoclax,Revumenib,Johnson and Johnson,Mantle Cell Lymphoma,Small lymphocytic lymphoma,FibroGen,Incyte,Polycythemia Vera,Secura Bio,teclistamab,Protagonist TherapeuticsRevuforj,Minjuvi

This hematology video covers major regulatory and guideline milestones across…

by LucidQuest

Hematology

Hematology Today—January 12, 2026

January 12, 2026fda approval,Multiple Myeloma,BioPharma and Tech News,CAR T Therapy,BCL2 Inhibitor,Johnson & Johnson,teclistamab,Acute Myeloid Leukemia,Hematology NewsDiffuse large B-cell lymphoma,Chronic myeloid leukemia

This week’s Hematology update spotlights key developments, regulatory…

by LucidQuest

Artificial_Intelligence

AI in Healthcare and Digital Health Today—January 12, 2026

January 12, 2026Headlamp Health,United States Food and Drug Administration,Insilico Medicine,National Institute for Health and Care Excellence,Genentech,Anthropic Claude,BioPharma and Tech News,MedPal AI,Anthropic,Lumos AI,OpenAI,reSET,AI in Healthcare and Digital Health,Rentosertib,Apple,ChatGPT Health,nvidia,OpenAI for Healthcare,Zealand Pharma,GlaxoSmithKline,Genmab,Mayo Clinic PlatformDanish Centre for AI Innovation,SimpleC

This AI in Healthcare and Digital Health roundup highlights accelerating…

by Timos Papagatsias

Lucid Diligence Brief - Tech

Lucid Diligence Brief: Chai Discovery and Eli Lilly biologics AI collaboration

January 12, 2026market access,biologics,drug discovery,AI in healthcare,clinical development,biopharma,Lucid Diligence Brief,diligence,platform partnerships,computational biologyR&D operations

Lucid Diligence Brief: Chai Discovery and Eli Lilly biologics AI collaboration…

by Timos Papagatsias

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Aurora Therapeutics launches to scale personalized CRISPR

January 11, 2026crispr,clinical trials,market access,Regulatory,gene editing,rare disease,biopharma,PKU,Lucid Diligence Brief,payer access,diligenceHTA

Lucid Diligence Brief: Aurora Therapeutics launches to scale personalized…

by Timos Papagatsias

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: AirNexis Therapeutics $200 million Series A for PDE3/4 in COPD

January 10, 2026Respiratory,clinical trials,COPD,biopharma,licensing,Lucid Diligence Brief,payer access,diligence,venture financing,China biotechPDE3/4

Lucid Diligence Brief: AirNexis Therapeutics $200 million Series A for PDE3/4…

by Timos Papagatsias

Public_Health

Public Health Today—9 January, 2026

January 9, 2026childhood obesity,Depression,BioPharma and Tech News,eczema,Narcolepsy,Public Health News,GLP-1 agonists,weight regain,blue zones,imatinib15-PGDH,sulfonylureas

Today's Public Health update spotlights key developments, regulatory…

by LucidQuest

Vaccines_News

Vaccines Video Recap—January 9, 2026

January 9, 2026International AIDS Vaccine Initiative,Dr. Reddy’s Laboratories,bayer,H5 influenza,pfizer,Plasmodium falciparum infection,sanofi,Opioid use disorder,Moderna,Hepatitis E,BioNTech,Herpes zoster,BioPharma and Tech News,European Commission,Vaccine news,malaria,Respiratory syncytial virus infection,Johnson and Johnson,Dynavax TechnologiesScripps Research Institute,ARMR Sciences

This Vaccines video recap covers major vaccine and immunization developments,…

by LucidQuest

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.